Repurposing FDA-approved drugs cetilistat, abiraterone, diiodohydroxyquinoline, bexarotene, and remdesivir as potential inhibitors against RNA dependent RNA polymerase of SARS-CoV-2: A comparative in silico perspective

Vaccines are undoubtedly the most effective means of combating viral diseases like COVID-19. However, there are risks associated with vaccination, such as incomplete viral deactivation or potential adverse effects in humans. However, designing and developing a panel of new drug molecules is always e...

Descripción completa

Detalles Bibliográficos
Autores principales: Shahabadi, Nahid, Zendehcheshm, Saba, Mahdavi, Mohammad, Khademi, Fatemeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729590/
https://www.ncbi.nlm.nih.gov/pubmed/36510496
http://dx.doi.org/10.1016/j.imu.2022.101147

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729590/
https://www.ncbi.nlm.nih.gov/pubmed/36510496
http://dx.doi.org/10.1016/j.imu.2022.101147

Ejemplares similares